The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients

2019 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients​
Pavo, N.; Arfsten, H.; Cho, A.; Goliasch, G.; Bartko, P. E.; Wurm, R. & Freitag, C. et al.​ (2019) 
Scientific Reports, 9(1).​ DOI: https://doi.org/10.1038/s41598-019-38867-2 

Copy

Further links

Documents & Media

document.pdf1.25 MBAdobe PDF

License

GRO License GRO License

Details

Authors
Pavo, Noemi; Arfsten, Henrike; Cho, Anna; Goliasch, Georg; Bartko, Philipp E.; Wurm, Raphael; Freitag, Claudia; Gisslinger, Heinz; Kornek, Gabriela; Strunk, Guido; Raderer, Markus; Zielinski, Christoph; Hülsmann, Martin
Issue Date
2019
Journal
Scientific Reports 
eISSN
2045-2322
Language
English

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations


Social Media